2012
1. Takanashi J, Okamoto N, Yamamoto Y, Hayashi S, Arai H, Takahashi Y, Maruyama K, Mizuno S, Shimakawa S, Ono H, Oyanagi R, Kubo S, Barkovich AJ, Inazawa J: Clinical and radiological features of Japanese patients with a severe phenotype due to CASK mutations. Am J Med Genet A. 158A:3112-8. 2012
2. Gaffney CJ, Oka T, Mazack V, Hilman D, Gat U, Muramatsu T, Inazawa J, Golden A, Carey DJ, Farooq A, Tromp G, Sudol M: Identification, basic characterization and evolutionary analysis of differentially spliced mRNA isoforms of human YAP1 gene. Gene. 509:215-22. 2012
3. Dobashi Y, Kimura M, Matsubara H, Endo S, Inazawa J, Ooi A: Molecular alterations in AKT and its protein activation in human lung carcinomas. Hum Pathol. 43:2229-40. 2012
4. Miyawaki Y, Kawachi H, Ooi A, Eishi Y, Kawano T, Inazawa J, Imoto I: Genomic copy-number alterations of MYC and FHIT genes are associated with survival in esophageal squamous-cell carcinoma. Cancer Sci. 103:1558-66. 2012
5.Matsumura S, Imoto I, Kozaki K, Matsui T, Muramatsu T, Furuta M, Tanaka S, Sakamoto M, Arii S, Inazawa J: Integrative array-based approach identifies MZB1 as a frequently methylated putative tumor-suppressor in hepatocellular carcinoma. Clin Cancer Res. 18:3541-3551. 2012
6. Honda S, Hayashi S, Nakane T, Imoto I, Kurosawa K, Mizuno S, Okamoto N, Kato M, Yoshihashi H, Kubota T, Nakagawa E, Goto Y, Inazawa J: The incidence of hypoplasia corpus callosum in patients with dup (X) (q28) involving MECP2 is associated with the location of distal breakpoints. Am J Med Genet A. 158A:1292-303. 2012
7. Akamatsu S, Takata R, Haiman CA, Takahashi A, Inoue T, Kubo M, Furihata M, Kamatani N, Inazawa J, Chen GK, Le Marchand L, Kolonel LN, Katoh T, Yamano Y, Yamakado M, Takahashi H, Yamada H, Egawa S, Fujioka T, Henderson BE, Habuchi T, Ogawa O, Nakamura Y, Nakagawa H: Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese. Nat Genet. 44:426-9. 2012
8. Yamamoto S, Tsuda H, Honda K, Takano M, Tamai S, Imoto I, Inazawa J, Yamada T, Matsubara O: ACTN4 gene amplification and actinin-4 protein overexpression drive tumour development and histological progression in a high-grade subset of ovarian clear-cell adenocarcinomas. Histopathology. 60:1073-1083. 2012
9. Kozaki K, Inazawa J: Tumor-suppressive microRNAs silenced by tumor-specific DNA hypermethylation in cancer cells. Cancer Sci. 103:837-45. 2012
10. Ono H, Imoto I, Kozaki K, Tsuda H, Matsui T, Kurasawa Y, Muramatsu T, Sugihara K, Inazawa J: SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation. Oncogene. 31:4923-34. 2012
11. Maeda M, Mitsui J, Soong B, Takahashi Y, Ishiura H, Hayashi S, Shirota Y, Ichikawa Y, Matsumoto H, Arai M, Okamoto T, Miyama S, Shimizu J, Inazawa J, Goto J, Tsuji S: Increased gene dosage of myelin protein zero causes Charcot-Marie-Tooth disease. Ann Neurol. 71:84-92. 2012
12. Okamoto N, Hayashi S, Masui A, Kosaki R, Oguri I, Hasegawa T, Imoto I, Makita Y, Hata A, Moriyama K, Inazawa J: Deletion at chromosome 10p11.23-p12.1 defines characteristic phenotypes with marked midface retrusion. J Hum Genet. J Hum Genet. 57:191-6. 2012
13. Bai H, Inoue J, Kawano T, Inazawa J: A transcriptional variant of the LC3A gene is involved in autophagy and frequently inactivated in human cancers. Oncogene. 31:4397-408. 2012
14. Ooi A, Inokuchi M, Harada S, Inazawa J, Tajiri R, Sawada-Kitamura S, Ikeda H, Kawashima H, Dobashi Y: Gene amplification of ESR1 in breast cancers-Fact or fiction? A fluorescence in situ hybridization and multiplex ligation-dependent probe amplification study. J Pathol. 227:8-16. 2012
15. Honda S, Satomura S, Hayashi S, Imoto I, Nakagawa E, Goto Y, Inazawa J: Concomitant microduplications of MECP2 and ATRX in male patients with severe mental retardation. J Hum Genet. 57:73-7.2012
16. Kurasawa Y, Kozaki K, Pimkhaokham A, Muramatsu T, Ono H, Ishihara T, Uzawa N, Imoto I, Amagasa T, Inazawa J: Stabilization of phenotypic plasticity through mesenchymal-specific DNA hypermethylation in cancer cells. Oncogene. 31:1963-74. 2012
2. Gaffney CJ, Oka T, Mazack V, Hilman D, Gat U, Muramatsu T, Inazawa J, Golden A, Carey DJ, Farooq A, Tromp G, Sudol M: Identification, basic characterization and evolutionary analysis of differentially spliced mRNA isoforms of human YAP1 gene. Gene. 509:215-22. 2012
3. Dobashi Y, Kimura M, Matsubara H, Endo S, Inazawa J, Ooi A: Molecular alterations in AKT and its protein activation in human lung carcinomas. Hum Pathol. 43:2229-40. 2012
4. Miyawaki Y, Kawachi H, Ooi A, Eishi Y, Kawano T, Inazawa J, Imoto I: Genomic copy-number alterations of MYC and FHIT genes are associated with survival in esophageal squamous-cell carcinoma. Cancer Sci. 103:1558-66. 2012
5.Matsumura S, Imoto I, Kozaki K, Matsui T, Muramatsu T, Furuta M, Tanaka S, Sakamoto M, Arii S, Inazawa J: Integrative array-based approach identifies MZB1 as a frequently methylated putative tumor-suppressor in hepatocellular carcinoma. Clin Cancer Res. 18:3541-3551. 2012
6. Honda S, Hayashi S, Nakane T, Imoto I, Kurosawa K, Mizuno S, Okamoto N, Kato M, Yoshihashi H, Kubota T, Nakagawa E, Goto Y, Inazawa J: The incidence of hypoplasia corpus callosum in patients with dup (X) (q28) involving MECP2 is associated with the location of distal breakpoints. Am J Med Genet A. 158A:1292-303. 2012
7. Akamatsu S, Takata R, Haiman CA, Takahashi A, Inoue T, Kubo M, Furihata M, Kamatani N, Inazawa J, Chen GK, Le Marchand L, Kolonel LN, Katoh T, Yamano Y, Yamakado M, Takahashi H, Yamada H, Egawa S, Fujioka T, Henderson BE, Habuchi T, Ogawa O, Nakamura Y, Nakagawa H: Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese. Nat Genet. 44:426-9. 2012
8. Yamamoto S, Tsuda H, Honda K, Takano M, Tamai S, Imoto I, Inazawa J, Yamada T, Matsubara O: ACTN4 gene amplification and actinin-4 protein overexpression drive tumour development and histological progression in a high-grade subset of ovarian clear-cell adenocarcinomas. Histopathology. 60:1073-1083. 2012
9. Kozaki K, Inazawa J: Tumor-suppressive microRNAs silenced by tumor-specific DNA hypermethylation in cancer cells. Cancer Sci. 103:837-45. 2012
10. Ono H, Imoto I, Kozaki K, Tsuda H, Matsui T, Kurasawa Y, Muramatsu T, Sugihara K, Inazawa J: SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation. Oncogene. 31:4923-34. 2012
11. Maeda M, Mitsui J, Soong B, Takahashi Y, Ishiura H, Hayashi S, Shirota Y, Ichikawa Y, Matsumoto H, Arai M, Okamoto T, Miyama S, Shimizu J, Inazawa J, Goto J, Tsuji S: Increased gene dosage of myelin protein zero causes Charcot-Marie-Tooth disease. Ann Neurol. 71:84-92. 2012
12. Okamoto N, Hayashi S, Masui A, Kosaki R, Oguri I, Hasegawa T, Imoto I, Makita Y, Hata A, Moriyama K, Inazawa J: Deletion at chromosome 10p11.23-p12.1 defines characteristic phenotypes with marked midface retrusion. J Hum Genet. J Hum Genet. 57:191-6. 2012
13. Bai H, Inoue J, Kawano T, Inazawa J: A transcriptional variant of the LC3A gene is involved in autophagy and frequently inactivated in human cancers. Oncogene. 31:4397-408. 2012
14. Ooi A, Inokuchi M, Harada S, Inazawa J, Tajiri R, Sawada-Kitamura S, Ikeda H, Kawashima H, Dobashi Y: Gene amplification of ESR1 in breast cancers-Fact or fiction? A fluorescence in situ hybridization and multiplex ligation-dependent probe amplification study. J Pathol. 227:8-16. 2012
15. Honda S, Satomura S, Hayashi S, Imoto I, Nakagawa E, Goto Y, Inazawa J: Concomitant microduplications of MECP2 and ATRX in male patients with severe mental retardation. J Hum Genet. 57:73-7.2012
16. Kurasawa Y, Kozaki K, Pimkhaokham A, Muramatsu T, Ono H, Ishihara T, Uzawa N, Imoto I, Amagasa T, Inazawa J: Stabilization of phenotypic plasticity through mesenchymal-specific DNA hypermethylation in cancer cells. Oncogene. 31:1963-74. 2012